FORMULATION AND IN-VITRO EVALUATION OF EFFERVESCENT TABLETS
Main Article Content
Keywords
Amlodipine besylate, Citric acid, Sodium bicarbonate, sodium starch glycolate, and Cross carmilose
Abstract
Hypertension is the commonest cause of high blood pressure in the elderly. The incidence increases with age advancement. Long acting dihydropyridines like amlodipine is very effective antihypertensive agent in management of ISH in elderly because of its vasodilatory as well as negative ionotropic effect. The main Aim of Present work is to Formulate and Evaluate Amlodipine besylate Effervescent and direct compression tablets tablets in order to enhance its Bio-availability by using Amlodipine besylate are the main ingredients in effervescent Tablets and Fast Disintegrating agents like sodium starch glycolate, Crosscarmilose. Different batches of (F1-F6) immediate release tablets of Amlodipine besylate were prepared by using various concentrations of Citric acid & Sodium bicarbonate as effervescent agents and sodium starch glycolate, Cross cormilose as super disintegrates. Evaluation parameters like thickness, hardness, friability, weight variation and disintegration tests of the formulations were found to be satisfactory. Among all prepared formulations F6 was shown desired release pattern than others. Formulations F1- F6 did not show the optimum drug release .Hence effervescent technique is superior to direct compression by super disintegrates. And thus the F6 formulation was found to be the desired immediate release tablet for the treatment of Hypertension
References
2. Yeole PG, Khan S, Shah K. Floating drug delivery systems: Need and development. Int. J. Pharm. Sci. 2005; 67:265-72.
3. Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Novel sustained release, swellable and bioadhesive gastro-retentive drug delivery system for Ofloxacin. Int. J. Pharm. 2006; 316:86-92.
4. Hwang SJ, Park K. Gastric retentive drug –delivery systems. Crit Rev Ther Drug Carrier Syst. 1998; 15:243-84.
5. Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F. Gastroretentive dosage forms: Overview and special case of Helicobactor pylori. J. Control Rel. 2006; 111:1-18.
6. Rouge N, Buri P, Doelkar E. Drug absorption sites in the gastrointestinal tract and dosage for site- specific delivery. Int. J. Pharm. 1996; 136:117-39.
7. Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohyxamic acid for the treatment of Helicobactor pylori. J. Pharm. Pharmacol. 2003; 55:607-13.
8. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of rapiglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Rel 2005; 107:300-9.
9. Deshpande AA, Shah NH, Rhodes CT and Malick W.Development of a novel controlled release system for gastric retention. Pharm. Res. 1997; 14(6): 815-819.
10. Klausner EA, Lavy E, Friedman M and Hoffman Expandable gastroretentive dosage form. J. Control. Rel. 2003; 90: 143-162.
11. Singh BN and Kim HK. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J.Control. Rel. 2000; 63: 235-59.
12. Barar FSK. Essentials of pharmacotherapeutis.3rd S. Chand and Company Ltd. New Delhi. 246
13. Gutierrez-rocca J, Omidian H and Shah K. Progress in Gastroretentive Drug Delivery System” Bussiness Briefing, Pharmatech. 2003: 152-156
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Shashikant D. Barhate
Principal and Professor, Shree Suresh Dada Jain Institute of Pharmaceutical Education and Research, Jamner, M.S
Dr. Sandip R. Pawar
Professor, Smt. Sharadchandrika Suresh Patil College of Pharmacy, Chopda-425107, M.S